로딩 중…
지수 로딩 중…
Tyra Biosciences, Inc.
TYRA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$32.04+0.50%
2026-08-03
Financials
Valuation Metrics
Tyra Biosciences, Inc.'s Market Cap is $1.91B. At end of 2025 it was $1.57B. Ranked #2086 of 3,112 in US market (top 67%), #804 of 1,445 on NASDAQ (top 56%), #140 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 52%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.91B | US#2,086/3,112 Sec#140/269 |
| Revenue | $0.00 | US#2,974/3,112 Sec#204/269 |
| Net Income | $-131M | US—/3,112 Sec—/269 |
| Total Assets | $412M | US#2,812/3,112 Sec#181/269 |
| Net Assets | $388M | US#2,423/3,112 Sec#139/269 |
| Value | ||
| P/B | 4.92x | US#2,161/3,112 Sec#140/269 |
| FCF Yield | -5.38% | US—/3,112 Sec—/269 |
| Profitability | ||
| ROE | -33.83% | US#2,646/3,112 Sec#136/269 |
| ROA | -31.82% | US#2,881/3,112 Sec#166/269 |
| Financial Health | ||
| Debt Ratio | 6.31% | US#63/3,112 Sec#29/269 |
| Total Debt | $6M | US#2,839/3,112 Sec#214/269 |
| FCF | $-102M | US#2,592/3,112 Sec#154/269 |
| Cash | $85M | US#2,308/3,112 Sec#186/269 |
| Current Ratio | 20.49x | US#124/3,112 Sec#32/269 |
| Performance | ||
| 1Y Return | 208.97% | US#102/3,112 Sec#32/269 |
| 1M Return | 4.64% | US#996/3,112 Sec#42/269 |
| From 52W High | -21.18% | US#1,779/3,112 Sec#115/269 |
| 1Y MDD | -35.82% | US#1,735/3,112 Sec#118/269 |
| Trading | ||
| Volume | 490,431 shares | US#2,090/3,112 Sec#203/269 |
| Trading Value | $16M | US#2,117/3,112 Sec#164/269 |
| Per Share | ||
| EPS | $-2.01 | US—/3,112 Sec—/269 |
| BPS | $4.35 | US#2,284/3,112 Sec#142/269 |